Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
3.540
-0.170 (-4.58%)
May 13, 2026, 11:27 AM EDT - Market open

Exagen Revenue

Exagen had revenue of $17.31M in the quarter ending March 31, 2026, with 11.67% growth. This brings the company's revenue in the last twelve months to $68.38M, up 20.55% year-over-year. In the year 2025, Exagen had annual revenue of $66.58M with 19.65% growth.

Revenue (ttm)
$68.38M
Revenue Growth
+20.55%
P/S Ratio
1.31
Revenue / Employee
$310,832
Employees
220
Market Cap
85.46M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202566.58M10.93M19.65%
Dec 31, 202455.64M3.09M5.89%
Dec 31, 202352.55M6.99M15.33%
Dec 31, 202245.56M-2.74M-5.66%
Dec 31, 202148.30M6.32M15.07%
Dec 31, 202041.98M1.59M3.93%
Dec 31, 201940.39M7.95M24.50%
Dec 31, 201832.44M5.63M21.01%
Dec 31, 201726.81M8.86M49.38%
Dec 31, 201517.95M6.28M53.87%
Dec 31, 201411.66M8.61M281.77%
Dec 31, 20133.06M2.13M229.91%
Dec 31, 2012926.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Myriad Genetics829.00M
Castle Biosciences339.92M
Fulgent Genetics320.35M
MDxHealth107.88M
FONAR105.34M
Biodesix96.10M
Prenetics Global92.39M
Burning Rock Biotech77.14M
Revenue Rankings